CSIMarket
 


Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 

Cumulative Aclaris Therapeutics Inc 's Leverage Ratio for Trailing Twelve Months Period

ACRS's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ACRS Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth 1.5 % 0.83 % 60.47 % 424.15 % 431.4 %
Y / Y Total Liabilities Growth 1.04 % -23.67 % -5.7 % 63.28 % 52.13 %
Leverage Ratio for Trailing Twelve Months Period 0.23 0.23 0.24 0.27 0.3
Total Ranking # 534 # 618 # 636 # 778 # 714
Seq. Equity Growth -6.75 % 30.83 % -8.69 % -8.88 % -7.37 %
Seq. Total Liabilities Growth 14.38 % -10.54 % -14.1 % 14.95 % -13.59 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 14.38% Aclaris Therapeutics Inc managed to unchange Leverage Ratio for Trailing Twelve Months Period in III. Quarter to 0.23, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 178 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Aclaris Therapeutics Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 534, from total ranking in previous quarter at 618.

What is Leverage Ratio?
Who are ACRS's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 179
Sector # 302
S&P 500 # 533


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.75 0.45 0.23
(Dec 31 2020)   (Jun 30 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Elite Pharmaceuticals Inc.  0.61 
Medavail Holdings Inc   0.60 
Hillstream Biopharma Inc   0.59 
Dar Bioscience Inc   0.59 
Adamis Pharmaceuticals Corp  0.59 
Mainz Biomed N v   0.58 
Vbi Vaccines Inc  0.57 
Tg Therapeutics inc   0.57 
Qualigen Therapeutics Inc   0.56 
Seelos Therapeutics Inc   0.55 
Sellas Life Sciences Group Inc   0.55 
Clearside Biomedical Inc   0.55 
Capricor Therapeutics inc   0.55 
Avenue Therapeutics inc   0.54 
Medicure Inc   0.54 
Nabriva Therapeutics Plc  0.54 
Reata Pharmaceuticals Inc   0.54 
Sinovac Biotech Ltd  0.53 
Otonomy Inc   0.53 
Eagle Pharmaceuticals inc   0.53 
Opiant Pharmaceuticals Inc   0.52 
Tango Therapeutics Inc   0.52 
Aeterna Zentaris Inc   0.51 
Integrated Biopharma Inc  0.51 
Marker Therapeutics inc   0.50 
Ibio inc   0.50 
Intercure Ltd   0.49 
Blueprint Medicines Corporation  0.49 
Anaptysbio inc  0.49 
Iterum Therapeutics Plc  0.48 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CPUH's Profile

Stock Price

CPUH's Financials

Business Description

Fundamentals

Charts & Quotes

CPUH's News

Suppliers

CPUH's Competitors

Customers & Markets

Economic Indicators

CPUH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071